Nuclear trafficking in health and disease

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

In eukaryotic cells, the cytoplasm and the nucleus are separated by a double-membraned nuclear envelope (NE). Thus, transport of molecules between the nucleus and the cytoplasm occurs via gateways termed the nuclear pore complexes (NPCs), which are the largest intracellular channels in nature. While small molecules can passively translocate through the NPC, large molecules are actively imported into the nucleus by interacting with receptors that bind nuclear pore complex proteins (Nups). Regulatory factors then function in assembly and disassembly of transport complexes. Signaling pathways, cell cycle, pathogens, and other physiopathological conditions regulate various constituents of the nuclear transport machinery. Here, we will discuss several findings related to modulation of nuclear transport during physiological and pathological conditions, including tumorigenesis, viral infection, and congenital syndrome. We will also explore chemical biological approaches that are being used as probes to reveal new mechanisms that regulate nucleocytoplasmic trafficking and that are serving as starting points for drug development.

Original languageEnglish (US)
Pages (from-to)28-35
Number of pages8
JournalCurrent Opinion in Cell Biology
Volume28
Issue number1
DOIs
StatePublished - Jun 2014

Fingerprint

Nuclear Pore
Cell Nucleus Active Transport
Cytoplasm
Nuclear Pore Complex Proteins
Nuclear Envelope
Health
Eukaryotic Cells
Virus Diseases
Cell Nucleus
Cell Cycle
Carcinogenesis
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cell Biology
  • Medicine(all)

Cite this

Nuclear trafficking in health and disease. / Mor, Amir; White, Michael A.; Fontoura, Beatriz M A.

In: Current Opinion in Cell Biology, Vol. 28, No. 1, 06.2014, p. 28-35.

Research output: Contribution to journalArticle

@article{fa1e26512cfb4eac9a8ccb26d69e15db,
title = "Nuclear trafficking in health and disease",
abstract = "In eukaryotic cells, the cytoplasm and the nucleus are separated by a double-membraned nuclear envelope (NE). Thus, transport of molecules between the nucleus and the cytoplasm occurs via gateways termed the nuclear pore complexes (NPCs), which are the largest intracellular channels in nature. While small molecules can passively translocate through the NPC, large molecules are actively imported into the nucleus by interacting with receptors that bind nuclear pore complex proteins (Nups). Regulatory factors then function in assembly and disassembly of transport complexes. Signaling pathways, cell cycle, pathogens, and other physiopathological conditions regulate various constituents of the nuclear transport machinery. Here, we will discuss several findings related to modulation of nuclear transport during physiological and pathological conditions, including tumorigenesis, viral infection, and congenital syndrome. We will also explore chemical biological approaches that are being used as probes to reveal new mechanisms that regulate nucleocytoplasmic trafficking and that are serving as starting points for drug development.",
author = "Amir Mor and White, {Michael A.} and Fontoura, {Beatriz M A}",
year = "2014",
month = "6",
doi = "10.1016/j.ceb.2014.01.007",
language = "English (US)",
volume = "28",
pages = "28--35",
journal = "Current Opinion in Cell Biology",
issn = "0955-0674",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Nuclear trafficking in health and disease

AU - Mor, Amir

AU - White, Michael A.

AU - Fontoura, Beatriz M A

PY - 2014/6

Y1 - 2014/6

N2 - In eukaryotic cells, the cytoplasm and the nucleus are separated by a double-membraned nuclear envelope (NE). Thus, transport of molecules between the nucleus and the cytoplasm occurs via gateways termed the nuclear pore complexes (NPCs), which are the largest intracellular channels in nature. While small molecules can passively translocate through the NPC, large molecules are actively imported into the nucleus by interacting with receptors that bind nuclear pore complex proteins (Nups). Regulatory factors then function in assembly and disassembly of transport complexes. Signaling pathways, cell cycle, pathogens, and other physiopathological conditions regulate various constituents of the nuclear transport machinery. Here, we will discuss several findings related to modulation of nuclear transport during physiological and pathological conditions, including tumorigenesis, viral infection, and congenital syndrome. We will also explore chemical biological approaches that are being used as probes to reveal new mechanisms that regulate nucleocytoplasmic trafficking and that are serving as starting points for drug development.

AB - In eukaryotic cells, the cytoplasm and the nucleus are separated by a double-membraned nuclear envelope (NE). Thus, transport of molecules between the nucleus and the cytoplasm occurs via gateways termed the nuclear pore complexes (NPCs), which are the largest intracellular channels in nature. While small molecules can passively translocate through the NPC, large molecules are actively imported into the nucleus by interacting with receptors that bind nuclear pore complex proteins (Nups). Regulatory factors then function in assembly and disassembly of transport complexes. Signaling pathways, cell cycle, pathogens, and other physiopathological conditions regulate various constituents of the nuclear transport machinery. Here, we will discuss several findings related to modulation of nuclear transport during physiological and pathological conditions, including tumorigenesis, viral infection, and congenital syndrome. We will also explore chemical biological approaches that are being used as probes to reveal new mechanisms that regulate nucleocytoplasmic trafficking and that are serving as starting points for drug development.

UR - http://www.scopus.com/inward/record.url?scp=84893734957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893734957&partnerID=8YFLogxK

U2 - 10.1016/j.ceb.2014.01.007

DO - 10.1016/j.ceb.2014.01.007

M3 - Article

VL - 28

SP - 28

EP - 35

JO - Current Opinion in Cell Biology

JF - Current Opinion in Cell Biology

SN - 0955-0674

IS - 1

ER -